MedTrace Logo

Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor

NCT06036368 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2024-08-21

No results posted yet for this study

Summary

This is a 6-week exploratory clinical study, designed to test whether treatment with peroneal electrical trans-cutaneous stimulation can have a beneficial effects on symptoms associated with Parkinson's diseases and essential tremor.

Conditions

Interventions

DEVICE

Peroneal electrical transcutaneous neuromodulation (peroneal eTNM®)

This is a non-invasive intervention, which utilizes direct trancutaneous, electrical stimulation of the peroneal nerve

Sponsors & Collaborators

  • Stimvia s.r.o.

    lead INDUSTRY

Principal Investigators

  • David Skoloudik, MD, PhD · Cerebrovaskulární poradna s.r.o., Ostrava

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-15
Primary Completion
2024-03-31
Completion
2024-06-30

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06036368 on ClinicalTrials.gov